海峽創新(300300.SZ)與中國五冶簽訂1.51億元建築工程施工專業分包合同
格隆匯 12 月 30日丨海峽創新(300300.SZ)公佈,近日,公司(“分包人”)與中國五冶集團有限公司(“中國五冶”或“承包人”)簽訂了《建築工程施工專業分包合同(建築工程)》,中國五冶將成都市環城生態修復綜合項目(東、西片區)(南片區)施工熊貓基地擴建一期項目-建築外裝幕牆工程分包給公司,合同金額約為(含税)1.51億元。
熊貓基地作為世界級大熊貓保護示範地,此次合同的簽訂及履行將進一步提升公司的影響力,此合同的順利履行也將對公司本年度及未來的經營業績產生一定的積極影響。此次合同總金額約為1.51億元,未來預計確認的收入佔公司2019年度經審計營業收入的30.59%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.